Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Speaking of EU, i noticed today on the corp. Presentaion they anticpate approval 2nd half 2017?
Fbg, what do you think Adage gives him on the A to F scale. As a spectator I would say Adage gives him/ADXS an F, yet they haven't sold. The Harvard boys are dumb maybe?
Fbg, ask yourself this: Why would Dan be purchasing stock every month, month after month? Is he deliberately trying to deceive us? Why the friggin heck is he buying stock? Why do you? Why did I just the other day? Why is this board so active compared to other boards? The problem today is when something happens and we as individuals clearly see something wrong (in our personal view), we HAVE to blame someone. Again I ask why is Dan buying every month? All LTSH know.
Interesting-
Galinpepimut-S has the potential to complement current therapies by destroying residual tumor cancer cells in remission and providing ongoing immune surveillance to avoid or significantly delay cancer recurrence. The treatment has shown positive survival and safety trends in phase II trials, not found in standard of care therapies. In 2017, galinpepimut-S will enter Phase III trials for Acute Myeloid Leukemia and Malignant Pleural Mesothelioma in the U.S. and Europe.
So Adxs hits the tumors body while Sellas grabs it by its ankles.
Nice to hear from you Donja, wish you would post more brother.
Feels good to say, I am a buyer tomorrow. First time in a long time for me to add to my core. It's not because I don't believe it's been a good buy but all expendable cash has been put into the farm. EU approval......BP partner.....breakthrough designation(???) bound.
Lol, all the old school boys hope you are right about the ride. Personally I am excited at what is to come.
"If we build a cure".....doctors and hospitals are out of "business."
Have you guys seen the goboldy commercials? Kind of free advertising for us but I wish Advaxis would do some of those.
Ya iggy, "breakdown your immune sytem w/ chemo/rad then come to us so we can build it back up to cure your cancer with"
There is a very, very lengthy sec filing regarding stendhal deal. I believe it was filed about 6 months ago if anyone is interested. I do recommend skimming it over.
I bet we have all done that a time or two.....adxs up 25,000%, i bet you did, lol. Heres to that being a foreshadowing event!
Advaxis now has 90 employees per yahoo finance.
Advaxis now has 90 employees per yahoo finance.
Advaxis now has 90 full time employees per yahoo finance.
Aratana Therapeutics Named Animal Pharm's Best Company in North America 2016.
(A copy and paste from terry on investor village)
Fbg, I have wrote dozens of emails to adxs IR and I have far less conviction than you. My wish as a holder of ADXS for 4 years now, is that you would voice your strong felt opinions to Advaxis IR/DO. Do you remember Shawshank Redemption?, keep writing letters/sending emails/calling them and eventually you will get a response.
Is it even feasible for a small company like Advaxis to expand from 10 trial sites to 150 without BP? I don't know, seems heavy for us
This statement is unbelievable, unacceptable, intolerable, and is a paradox of bizarreness when attributiing trust and reliability by Advaxis in this company. Is Advaxis management inept in holding Aratana to their deadlines?
James, I think with the 2 latest positions filled that puts us around 90 employees.
Or, fbg.....? Who does that and why would they do it? Hard to think its not a signal and at the same time, a subtle thump in the balls. GLTAL's.
Obi10, you keep talking but say nothing. Curious when you will give something of substance. Plagiarize, copy and paste, give us something to grasp onto to that has some sort of meaning.
I believe it was a rep from Adage that asked during the last conference call, if mid double digits meant 50% or 60% range. I remember Dan responded, it would be inappropriate for him to speculate.
Phase 3 AIM2CERV trial expected to enroll 450 patients at over 150 locations. 150 locations? That many would demand BP help, imo.
completely agree, james. we boosted pd1, and not the other way around. like i said before, "who needs who?".......the answer is BOTH!
From what I have seen we have been, as a monotherapy, the more efficacious than in a combo regimen. IMO, there is no doubt we can boost almost any regimen given the data. That is why we are chasing infectious diseases now, no? From many different forms of cancers, to personalized cancer treatments (NEO). If I am wrong please correct me.
Hey guys long time reader first time poster, lol. I just thought I would add an email response from Mayes I got today (yes I finally got a response). I was reading here that some were confused about whether we announced the start of ph3, and if the first patient Has been dosed, and if we would pr that. Mayes said they did announce ph3 had began in November alongside the commencement of the expansion of PSA trial with Keytruda. He also stated patients are not dosed until CCRT regimen is finished. My take is that some patients which will eventually receive AXAL have already been enrolled just not dosed yet